Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; and REBORN for the treatment of breakthrough cancer pain. It also develops novel prescription drugs and treatments to relieve symptoms associated with advanced cancer pain, chronic pain, Acute Respiratory Distress Syndrome, sepsis and ophthalmic disease. The company is headquartered in Orléans, Canada.
Frequently asked questions
What sector does Tetra Bio-Pharma Inc. (TBPMQ) operate in?
Tetra Bio-Pharma Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Tetra Bio-Pharma Inc. (TBPMQ) current stock price?
As of the latest data, Tetra Bio-Pharma Inc. stock price is $0.00, with a previous close of $0.00.
What is Tetra Bio-Pharma Inc. (TBPMQ) current market capitalization?
Tetra Bio-Pharma Inc. market cap is approximately 84.67 thousand.
What is Tetra Bio-Pharma Inc. (TBPMQ) Earnings Per Share (EPS)?
The trailing EPS is -$0.06.
Does Tetra Bio-Pharma Inc. (TBPMQ) pay dividends?
No. Tetra Bio-Pharma Inc. does not pay a dividend.
What is Tetra Bio-Pharma Inc. (TBPMQ) beta (volatility) score?
Tetra Bio-Pharma Inc. has a beta of 31.712, indicating very high volatility compared to the market.